Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.

Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.

Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

Hemerion Therapeutics

Org chart

Teams

Offices